Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023

被引:4
|
作者
Yanagisawa, Takafumi [1 ,2 ]
Kawada, Tatsushi [1 ,3 ]
von Deimling, Markus [1 ,4 ]
Laukhtina, Ekaterina [1 ,5 ]
Kimura, Takahiro [2 ]
Shariat, Shahrokh F. [1 ,6 ,7 ,8 ,9 ,10 ]
机构
[1] Med Univ Vienna, Comprehens Canc Ctr, Dept Urol, Vienna, Austria
[2] Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan
[3] Okayama Univ, Dept Urol Dent & Pharmaceut Sci, Grad Sch Med, Okayama, Japan
[4] Univ Med Ctr Hamburg Eppendorf, Dept Urol, Hamburg, Germany
[5] Sechenov Univ, Inst Urol & Reprod Hlth, Moscow, Russia
[6] Univ Jordan, Dept Special Surg, Div Urol, Amman, Jordan
[7] Univ Texas Southwestern Med Ctr Dallas, Dept Urol, Dallas, TX USA
[8] Charles Univ Prague, Fac Med 2, Dept Urol, Prague, Czech Republic
[9] Weill Cornell Med Coll, Dept Urol, New York, NY USA
[10] Karl Landsteiner Inst Urol & Androl, Vienna, Austria
关键词
lymph node dissection; lymphadenectomy; upper tract urothelial carcinoma; PROSPECTIVE CLINICAL-TRIAL; RADICAL NEPHROURETERECTOMY; RISK STRATIFICATION; LYMPHADENECTOMY; MANAGEMENT; OUTCOMES; TIME; METASTASES; QUALITY; BLADDER;
D O I
10.1097/MOU.0000000000001097
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of reviewAlthough lymph node dissection (LND) during radical nephroureterectomy (RNU) is recommended for high-risk nonmetastatic upper tract urothelial carcinoma (UTUC), adherence to guidelines remains insufficient in clinical practice. Therefore, this review aims to comprehensively summarize the current evidence regarding the diagnostic, prognostic, and therapeutic impact of LND during RNU in UTUC patients.Recent findingsClinical nodal staging using conventional CT scan has low sensitivity (25%) and diagnostic accuracy [area under the curve (AUC): 0.58] in UTUC, suggesting the importance of LND for obtaining accurate N-staging. Patients with pathological node-positive (pN+) disease have poor disease-free survival (DFS), cancer-specific survival (CSS), and overall survival (OS) compared with those with pN0. In addition, population-based studies showed that patients who underwent LND improved CSS and OS than those who did not, even in patients who received adjuvant systemic therapy. The number of lymph nodes removed has also been shown to be associated with improved CSS and OS, even in pT0 patients. Template-based LND should be performed as the extent of lymph node is more important than the number of lymph nodes. Robot-assisted RNU may facilitate performing a meticulous LND compared with a laparoscopic approach. Postoperative complications such as lymphatic and/or chylous leakage are increased but adequately manageable. However, the current evidence is not supported by high-quality studies.Based on the published data, LND during RNU is a standard procedure for high-risk nonmetastatic UTUC, owing to its diagnostic, staging, prognostic, and, potentially, therapeutic benefits. Template-based LND should be offered to all patients who are planned for RNU for high-risk nonmetastatic UTUC. Patients with pN+ disease are optimal candidates for adjuvant systemic therapy. Robot-assisted RNU may facilitate meticulous LND compared with laparoscopic RNU.
引用
收藏
页码:258 / 268
页数:11
相关论文
共 50 条
  • [31] Lymph Node Dissection in Upper Tract Urothelial Cancer: Ready for Prime Time?
    Tissot, Gabrielle
    Xylinas, Evanguelos
    JOURNAL OF UROLOGY, 2023, 209 (03): : 462 - 463
  • [32] Prospective clinical trial of the merits of retroperitoneal lymph node dissection at the time of nephroureterectomy for upper tract urothelial carcinoma
    Rao, S. R.
    Correa, J. J.
    Sexton, W. J.
    Pow-Sang, J. M.
    Spiess, P. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [33] THE PROGNOSTIC IMPACT OF LYMPH NODE DISSECTION FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA IN PATIENT WITH CLINICALLY NODE-NEGATIVE DISEASE
    Hsieh Hsiang-Chen
    Lin Chia-Yen
    Chen Chuan-Shu
    Chiu Kun-Yuan
    JOURNAL OF UROLOGY, 2020, 203 : E1253 - E1253
  • [34] A Comprehensive Review on Upper Tract Urothelial Carcinoma: An Update in 2023
    Ghoreifi, Alireza
    Djaladat, Hooman
    CANCERS, 2024, 16 (09)
  • [35] Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer
    Secin, Fernando P.
    Koppie, Theresa M.
    Martinez Salamanca, Juan I.
    Bokhari, Shahid
    Raj, Ganesh V.
    Olgac, Semra
    Serio, Angel
    Vickers, Andrew
    Bochner, Bernard H.
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (01) : 26 - 32
  • [36] The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial Cancer
    Slusarczyk, Aleksander
    Zapala, Piotr
    Piecha, Tomasz
    Rajwa, Pawel
    Moschini, Marco
    Radziszewski, Piotr
    CANCERS, 2023, 15 (18)
  • [37] Tumors of the upper gastro-intestinal tract - Indications and extent of lymph node dissection
    Sendler, A.
    CHIRURG, 2010, 81 (02): : 103 - +
  • [38] UTILIZATION OF LYMPHADENECTOMY AND PREDICTORS OF LYMPH NODE YIELD IN UPPER TRACT UROTHELIAL CARCINOMA
    Venkat, Siv
    Lewicki, Patrick
    Basourakos, Spyridon
    Scherr, Douglas
    JOURNAL OF UROLOGY, 2021, 206 : E864 - E865
  • [39] Prognostic assessments in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy and systematic regional lymph node dissection
    Sato, Ryo
    Watanabe, Kyohei
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    Miyake, Hideaki
    UROLOGIA JOURNAL, 2022, 89 (03) : 354 - 357
  • [40] Current trends in site-specific lymph node dissection for upper tract urothelial carcinoma: precise staging and survival
    Jia, Yige
    Wu, Kan
    Li, Xiang
    INTERNATIONAL JOURNAL OF SURGERY, 2025, 111 (01) : 1677 - 1679